The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients
Abstract
Researchers have reported that serum brain-derived neurotrophic factor (sBDNF) of drug-free depressed patients are lower than those of healthy controls and proposed that low sBDNF levels might reflect failure of neuronal plasticity in depression. In this study, we compared sBDNF levels of depressed patients (n = 28) before and after 8 weeks of antidepressant treatment, with those of healthy controls (n = 18) to test the hypothesis that initially low sBDNF levels of drug-free depressed patients will increase parallel with their clinical response to antidepressant treatment. The severity of depression and response to treatment were assessed with Hamilton Rating Scale for Depression (HAM-D). sBDNF was assayed with the sandwich ELISA method. Baseline sBDNF levels of patients (mean, 20.8 ng/ml; [S.D., 6.7]) were significantly lower than those of controls (mean, 26.8 ng/ml; [S.D., 9.3]; p = 0.015), and were negatively correlated with HAM-D scores (r = -0.49, p = 0.007). After 8 weeks of treatment, sBDNF levels of patients had increased significantly (mean, 33.3 ng/ml; [S.D., 9.9]; p < 0.001) and no longer differed from those of controls. These results support the hypothesis that BDNF might play a critical role in the pathophysiology of major depressive disorder and successful antidepressant treatment increases the attenuated BDNF levels in depressed patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both MDD patients [57–59] and animal models of depression [60, 61] show a remarkable reduction in serum BDNF levels.”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [57]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Neurotrophins and Neuronal Plasticity
Thoenen, H. (1995) · Science · doi:10.1126/science.270.5236.593 · Cited by 1,927
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.973 · Cited by 1,610
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Flagged first, then by citations
1 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 373
Trajkovska, V., Vinberg, M., Aznar, S., Knudsen, G. M., & Kessing, L. V. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.09.004 · Cited by 31
BDNF downregulates 5-HT2A receptor protein levels in hippocampal cultures
Trajkovska, V., Santini, M. A., Marcussen, A. B., Thomsen, M. S., Hansen, H. H., Mikkelsen, J. D., Arneberg, L., Kokaia, M., Knudsen, G. M., & Aznar, S. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.06.013 · Cited by 30
Aznar, S., Klein, A. B., Santini, M. A., Knudsen, G. M., Henn, F. A., Gass, P., & Vollmayr, B. (2010) · Synapse · doi:10.1002/syn.20773 · Cited by 30
Gau, Y. A., Liou, Y., Yu, Y. W. ‐., Chen, T., Lin, M., Tsai, S., & Hong, C. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30646 · Cited by 29
Xiao, L., Kish, V. L., Benders, K. M., & Wu, Z.-X. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv117 · Cited by 28
Freire, T. F. V., Fleck, M. P. D. A., & da Rocha, N. S. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.02.013 · Cited by 31
Pettai, K., Milani, L. A., Tammiste, A., Võsa, U., Kolde, R., Eller, T., Nutt, D., Metspalu, A., & Maron, E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.06.007 · Cited by 27
Nase, S., Köhler, S., Jennebach, J., Eckert, A., Schweinfurth, N., Gallinat, J., Lang, U. E., & Kühn, S. (2016) · Neurosignals · doi:10.1159/000442607 · Cited by 28
Yamaura, K., Bi, Y., Ishiwatari, M., 大石, 信., Fukata, H., & Ueno, K. (2013) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.30.1019 · Cited by 28
Ladea, M., & Bran, M. (2013) · PubMed · Cited by 25
Ai, M., Wang, J., Chen, J., Wang, W., Xu, X., Gan, Y., Li, X., Gou, X., Cao, J. M., Lv, Z., et al. (2019) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s201187 · Cited by 27
Halaris, A. E., & Cook, J. T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_21 · Cited by 27
Russell, A. L., Grimes, J. M., Larco, D. O., Cruthirds, D. F., Westerfield, J., Wooten, L., Keil, M. F., Weiser, M. J., Landauer, M. R., Handa, R. J., et al. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.011 · Cited by 25
Paumier, K. L., Sortwell, C. E., Madhavan, L., Terpstra, B. T., Celano, S. L., Green, J. J., Imus, N. M., Marckini, N., Daley, B. F., Steece‐Collier, K., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.262 · Cited by 23
Dong, B., Shilpa, B. M., Shah, R., Goyal, A., Xie, S., Bakalian, M. J., Suckow, R. F., Cooper, T. B., Mann, J. J., Arango, V., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.10.010 · Cited by 25
Tiwari, S., Qi, L., Wong, J. W., & Han, Z. (2022) · Brain and Behavior · doi:10.1002/brb3.2581 · Cited by 23
Yamaura, K., Tanaka, R., Bi, Y., Fukata, H., 大石, 信., Sato, H., Mori, C., & Ueno, K. (2015) · Pharmacognosy Magazine · doi:10.4103/0973-1296.157702 · Cited by 24
Juckel, G., Schumacher, C., Giegling, I., Assion, H., Mavrogiorgou, P., Pogarell, O. M., Mulert, C., Hegerl, U., Norra, C., & Rujescu, D. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.11.006 · Cited by 23
Wu, J., Song, J., He, Y., Li, Z., Deng, H., Huang, Z.-M., Xie, X., Wong, N. M. L., Tao, J., Lee, T. M. C., et al. (2023) · Sports Medicine - Open · doi:10.1186/s40798-023-00637-w · Cited by 25
Huang, T., Hung, Y.-Y., Lee, C., & Chen, R. (2012) · Neuropsychobiology · doi:10.1159/000328991 · Cited by 22
Oh, H.-M., Lee, J., Kim, S.-W., Oh, Y.-T., Kim, W., Lee, S.-B., Cho, Y.-R., Jeon, Y.-J., Cho, J.-H., & Son, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01674 · Cited by 23
The link between BDNF and platelets in neurological disorders
Bouhaddou, N., Mabrouk, M., Atifi, F., Bouyahya, A., & Zaid, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39278 · Cited by 22
Oral, E., Kirkan, T. S., Yıldırım, A., Kotan, Z. K., Cansever, Z., Özcan, H., Aliyev, E., & Güleç, M. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.03.001 · Cited by 21
Serum Brain-Derived Neurotrophic Factor Levels and Cocaine-Induced Transient Psychotic Symptoms
Corominas, M., Roncero, C., Eiroá‐Orosa, F. J., Marta Ribasés, A., Barral, C., Daigre, C., Martínez‐Luna, N., Sánchez‐Mora, C., Ramos‐Quiroga, J. A., & Casas, M. (2013) · Neuropsychobiology · doi:10.1159/000353259 · Cited by 25
Zou, Y., Wang, Y., Liu, P., Feng, X., Wang, B., Zang, T., Yu, X., Wei, J., Liu, Z., Liu, Y., et al. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1099 · Cited by 21
Novel routes to bipolar disorder drug discovery
Hoertel, N., de Maricourt, P., & Gorwood, P. A. P. M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.804057 · Cited by 21
Saitoh, K., Furihata, R., Kaneko, Y., Suzuki, M., Takahashi, S., & Uchiyama, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199765 · Cited by 21
Tagliarini, C., Carbone, M. G., Pagni, G., Marazziti, D., & Pomara, N. (2020) · CNS Spectrums · doi:10.1017/s1092852920001959 · Cited by 21
Cholewinski, T., Pereira, D., Moerland, M., & Jacobs, G. E. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211036814 · Cited by 20
Takebayashi, N., Maeshima, H., Baba, H., Nakano, Y., Satomura, E., Kita, Y., Namekawa, Y., Nomoto, H., Suzuki, T., & Arai, H. (2012) · Depression and Anxiety · doi:10.1002/da.21933 · Cited by 20
van Donkelaar, E. L., van den Hove, D., Blokland, A., Steinbusch, H. W. M., & Prickaerts, J. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.06.012 · Cited by 21
Tafseer, S., Gupta, R., Ahmad, R. S., Jain, S., Bhatia, M. S., & Gupta, L. K. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173073 · Cited by 19
Thakare, V. N., Lakade, S. H., Mahajan, M. P., Kulkarni, Y. P., Dhakane, V. D., Harde, M. T., & Patel, B. M. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173992 · Cited by 19
Yasui‐Furukori, N., Tsuchimine, S., Nakagami, T., Fujii, A., Sato, Y., Tomita, T., Yoshizawa, K., Inoue, Y., & Kaneko, S. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1192 · Cited by 19
Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria.
Ristevska-Dimitrovska, G., Shishkov, R., Gerazova, V., Vujovik, V., Stefanovski, B., Novotni, A., Marinov, P., & Filov, I. (2013) · PubMed · Cited by 19
Varambally, S. S., Naveen, G., Rao, M., Thirthalli, J., Sharma, R., Christopher, R., & Gangadhar, B. N. (2013) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.116311 · Cited by 19
Long Non-coding RNA in Neurons: New Players in Early Response to BDNF Stimulation
Aliperti, V., & Donizetti, A. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00015 · Cited by 19
Lohoff, F. W., & Berrettini, W. H. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch12 · Cited by 19
Mechanisms of Psychiatric Comorbidities in Epilepsy
Maguire, J. L. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_192 · Cited by 22
Gagne, C., Piot, A., & Brake, W. G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.797577 · Cited by 18
Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats
Verma, H., Bhattacharjee, A., Shivavedi, N., & Nayak, P. K. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02273-9 · Cited by 17
Cooke, J. D., Cavender, H. M., Lima, H. K., & Grover, L. M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3587-1 · Cited by 18
Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder
Oral, E., Özcan, H., Kirkan, T. S., Aşkın, S., Gulec, M., & Aydın, N. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0398-z · Cited by 17
Mandelli, L., Mazza, M., Martinotti, G., Tavian, D., Colombo, E., Missaglia, S., Nicola, M. D., Ronchi, D. D., Negri, G., Colombo, R., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109353463 · Cited by 17
Sharma, A. H. A. (2015) · Journal of Depression & Anxiety · doi:10.4172/2167-1044.1000179 · Cited by 18
Translational Functional Neuroimaging in the Explanation of Depression
Stoyanov, D., Kandilarova, S., & Borgwardt, S. (2017) · Balkan Medical Journal · doi:10.4274/balkanmedj.2017.1160 · Cited by 16
Kenna, H. A., Reynolds-May, M. F., Stepanenko, A., Ketter, T. A., Hallmayer, J. F., & Rasgon, N. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.054 · Cited by 15
Caruncho, H. J., & Baltanás, T. R. (2010) · Revista de Neurología · doi:10.33588/rn.5008.2010177 · Cited by 15
Zheng, X., Chen, F., Zheng, T., Huang, F., Chen, J., & Tu, W. (2016) · Medicine · doi:10.1097/md.0000000000003559 · Cited by 14
Shin, Y., Chun, Y. T., Lim, S. W., Luo, K., Quan, Y., Cui, S., Ko, E. J., Chung, B. H., Lee, J., Hong, S.-N., et al. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00062-6 · Cited by 14
Shajarian, M., Alsahebfosoul, F., & Etemadifar, M. (2021) · NeuroImmunoModulation · doi:10.1159/000515595 · Cited by 16
Eker, S. S., Yavaşçi, E. Ö., Cangür, Ş., Kırlı, S., & Sarandöl, E. (2014) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.13 · Cited by 14
Decreased serum BDNF levels in major depressive patients
Varma, G. S., Enli, Y., Uğurlu, T. T., Alaçam, H., & Oğuzhanoğlu, N. K. (2011) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2011.09.001 · Cited by 14
Zhu, Y., Wang, L., Zhao, D., Cheng-Long, W. A. N. G., Zhang, R., Fei, W., Wang, J., & Zhang, J. (2020) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(20)60030-9 · Cited by 13
Orosz, A., Federspiel, A., Eckert, A., Seeher, C., Dierks, T., Tschitsaz, A., & Cattapan, K. (2020) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2539 · Cited by 17
Luo, Y., Zhong, Z., Li, H., Wang, L., Guo, D., Dong, X., Liu, J., Xie, M., Wu, M., Xiang, Y., et al. (2023) · Pharmaceutical Biology · doi:10.1080/13880209.2023.2246531 · Cited by 12
Targeting BDNF with acupuncture: A novel integrated strategy for diabetes and depression comorbidity
Zhang, K., Zhai, W., Ge, X., Zhang, X., Tian, W., & Zhai, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22798 · Cited by 14
BDNF-related mutations in major depressive disorder: a systematic review
Hartig, J., & Nemeş, B. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.22 · Cited by 14
Yoshimura, R., Okamoto, N., Chibaatar, E., Natsuyama, T., & Ikenouchi, A. (2023) · Biomedicines · doi:10.3390/biomedicines11020584 · Cited by 14
Feasibility of an Exercise Program for Older Depressive Inpatients
Heißel, A., Vesterling, A., White, S. A., Kallies, G., Behr, D., Arafat, A. M., Reischies, F. M., Heinzel, S., & Budde, H. (2015) · GeroPsych · doi:10.1024/1662-9647/a000134 · Cited by 13
Hasselbalch, B. J., Knorr, U., Bennike, B., Hasselbalch, S. G., Soendergaard, M. G., & Kessing, L. V. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01831.x · Cited by 11
Jeon, S., Lee, C., Liu, Q. F., Kim, G. W., Koo, B., & Pak, S. C. (2014) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-014-0077-2 · Cited by 12
[BDNF measurement in stress-related mood disorders: a review of clinical studies].
Aydemır, Ö., & Deveci, A. (2009) · PubMed · Cited by 10
Park, Y. M., Lee, B. H., Um, T. H., & Kim, S. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s64913 · Cited by 11
Min, H. J., Cho, H. S., Kim, S. J., Seok, J., Lee, E. M., & Jon, D. (2012) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2012.10.3.163 · Cited by 11
Turkey's contribution to medicine: Main institutions, fields and publications
Onat, A. (2013) · Turkish Journal of Surgery · doi:10.5152/ucd.2013.2314 · Cited by 10
The Clinician Scientist Training Program in Iran: Catalyzing Clinical Science Advancements
Moghaddan, H. S., & Akhondzadeh, S. (2023) · Avicenna Journal of Medical Biotechnology · doi:10.18502/ajmb.v15i3.12921 · Cited by 11
Bahmani, M., Mehrtabar, S., Jafarizadeh, A., Zoghi, S., Heravi, F. S., Abbasi, A., Sanaie, S., Rahnemayan, S., & Leylabadlo, H. E. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010281892240116081031 · Cited by 10
Yoshimura, R., Tsuji, K., Ueda, N., & Nakamura, J. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a944 · Cited by 10
Neurotrophic Factors and Antidepressant Action: Recent Advances
O’Leary, O. F., & Ċastrén, E. (2010) · Modern trends in psychiatry · doi:10.1159/000319514 · Cited by 11
Remission and recovery in depression treatment
Trivedi, M. H., Kleiber, B., & Greer, T. L. (2005) · Drug Development Research · doi:10.1002/ddr.20034 · Cited by 10
The role of genetic variation of BDNF gene in antidepressant-induced mania in bipolar disorder
Ferreira, A. D. A., Neves, F. S., Pimenta, G. J. G. S., Mello, M. P., de Miranda, D. M., Romano‐Silva, M. A., Marco, L. A. D., & Corrêa, H. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.036 · Cited by 10
Tavakoli, R., Yaghooti, H., Daghagheleh, R., Yousofi, R., & Rahimifar, P. (2017) · Asian Biomedicine · doi:10.1515/abm-2018-0016 · Cited by 9
Reddy, N. R., & Krishnamurthy, S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.003 · Cited by 9
Serum brain-derived neurotrophic factor level in elderly women depression: A community-based study
Hashizume, M., Hachisu, M., Yoshida, H., Kim, M., Kim, H. K., Amano, Y., Hasegawa, C., Suzuki, T., & Ihara, K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.08.012 · Cited by 9
Differences in Cognitive Outcomes After ECT Depending on BDNF and COMT Polymorphisms
Bennett, D., Currie, J., Fernie, G., Perrin, J. S., & Reid, I. (2016) · Journal of Ect · doi:10.1097/yct.0000000000000325 · Cited by 8
Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion
Yasuhara, T., Kin, K., Borlongan, C., & Date, I. (2018) · Brain Circulation · doi:10.4103/bc.bc_17_18 · Cited by 8
Different Mechanisms Between Melancholic and Atypical Depression
Lee, H., & Kim, Y. (2015) · InTech eBooks · doi:10.5772/59959 · Cited by 10
Antidepressant Psychopharmacology and the Social Brain
Novick, A. M. (2011) · Psychiatry · doi:10.1521/psyc.2011.74.1.72 · Cited by 7
Rapid and Sensitive Detection of Brain-Derived Neurotrophic Factor with a Plasmonic Chip
Tawa, K., Satoh, M., Uegaki, K., Hara, T., Kojima, M., Kumanogoh, H., Aota, H., Yokota, Y., Nakaoki, T., Umetsu, M., et al. (2013) · Japanese Journal of Applied Physics · doi:10.7567/jjap.52.06gk01 · Cited by 7
Aldoghachi, A. F., Cheah, P.-S., & Ling, K. (2020) · Neuroscience Research Notes · doi:10.31117/neuroscirn.v3i3.50 · Cited by 7
[The neurobiology of burnout: the hypothalamus-pituitary-adrenal gland axis and other findings].
Sertöz, Ö. Ö., Binbay, T., & Mete, H. E. (2008) · PubMed · Cited by 7
Movement impairment: Focus on the brain
Adami, R., & Bottai, D. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23711 · Cited by 7
Brammanathan, S., Jain, R., Sarkar, S., Raghav, R., & Sagar, R. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2192985 · Cited by 6
Gupta, R., Ghosh, R., Bhatia, M. S., Tripathi, A., & Gupta, L. K. (2023) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2023-006 · Cited by 6
Babii, Y., Pałucha-Poniewiera, A., Rafało-Ulińska, A., Brański, P., & Pilc, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00630-4 · Cited by 7
Wang, Y., Deng, Y., Feng, M., Chen, J., Zhong, M., Han, Z., Zhang, Q., & Sun, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119249 · Cited by 7
Aksoy, H. K., Ergun, T., Akkіprіk, M., Eyüboğlu, İ. P., Gençosmanoğlu, D. S., Ünalan, G. P. C., & Yöney, H. (2021) · Dermatologic Therapy · doi:10.1111/dth.14872 · Cited by 6
Khorasanian, A. S., Jazayeri, S., Omidi, N., Booyani, Z., Morvaridi, M., Tehrani‐Doost, M., Hoseini, A. F., Nejatian, M., & Aryaeian, N. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3692 · Cited by 6
Vega‐Rivera, N. M., González-Trujano, M. E., Luna‐Angulo, A. B., Sánchez‐Chapul, L., & Estrada-Camarena, E. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1211663 · Cited by 7
He, B., Xu, D., Zhang, C., Zhang, L., & Wang, H. (2018) · Toxicology Research · doi:10.1039/c7tx00133a · Cited by 6
Maron, E., Tõru, I., Mäemets, K., Sepp, S., Vasar, V., Shlik, J., & Zharkovsky, A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089600 · Cited by 6
Pae, C. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.10.009 · Cited by 6
The role of neuroinflammation in juvenile bipolar disorder
Serra, G., Chiara, L. D., Marangoni, C., & Faedda, G. L. (2015) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.167303 · Cited by 5
Neurotrophic Factors and Major Depressive Disorder
Zhang, X., Jin, L., Sha, W., & Bu, R. (2015) · InTech eBooks · doi:10.5772/59373 · Cited by 6
Neurotrophic Factors in Etiology and Treatment of Mood Disorders
Duman, R. S. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn019 · Cited by 5
Neurobiological correlates of burnout
Sousa, A. D., & Sail, D. B. (2021) · Telangana Journal of Psychiatry · doi:10.4103/tjp.tjp_44_21 · Cited by 4
Li, J., Wang, Y., Zhang, Y., Liu, M., Rong, X., & Jiang, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1476558 · Cited by 4
Long-Term Adaptive Changes Induced by Antidepressants: From Conventional to Novel Therapies
Mnie‐Filali, O., Abrial, E., Lambás‐Señas, L., & Haddjeri, N. (2013) · InTech eBooks · doi:10.5772/54553 · Cited by 5
Hunting for Peripheral Biomarkers to Support Drug Development in Psychiatry
Domenici, E., Muglia, P., & Merlo‐Pich, E. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_16 · Cited by 4
Metadata
- Authors
- Gonul, A. S., Akdeniz, F., Taneli, F., Donat, O., Eker, Ç., & Vahip, S.
- Affiliations
- Ege University (TR)
- Manisa Celal Bayar University (TR)
- ORCID
- Venue
- European Archives of Psychiatry and Clinical Neuroscience
- Published
- 2005-04-06
- Volume
- 255
- Issue
- 6
- Pages
- 381-386
- ISSN
- 0003-9373 (ISSN-L)
- 0940-1334
- 1433-8491
- OpenAlex
- W2055040288
- Cited by
- 375
- References
- 50
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 12 · 2022: 13 · 2021: 10 · 2020: 14 · 2019: 12 · 2018: 16 · 2017: 11 · 2016: 16 · 2015: 23 · 2014: 18 · 2013: 29 · 2012: 25
- FWCI
- 15.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Archives of Psychiatry and Clinical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ege Üniversitesi
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- brain-derived neurotrophic factor, serum BDNF, major depressive disorder, antidepressant response, depression pathophysiology, neuroplasticity, treatment response biomarkers, depression severity
- MeSH terms
- Adult, Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Enzyme-Linked Immunosorbent Assay, Female, Follow-Up Studies, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Brain-Derived Neurotrophic Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review